Colon Adenocarcinoma — Trials

Colon Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

132 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 15
Ph III recruiting: 2
Growth YoY: —
Industry share: 11%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00835679	Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery	terminated	Early Phase 1	9	National Cancer Institute (NCI)NIH	1	May 23, 2014	clinicaltrials
NCT01403103	Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer	withdrawn	Early Phase 1	0	Case Comprehensive Cancer CenterOTHER	0	Jan 17, 2014	clinicaltrials